When.com Web Search

  1. Ads

    related to: best time to give lipitor for sale

Search results

  1. Results From The WOW.Com Content Network
  2. AstraZeneca's Crestor Fails to Best Lipitor in Study - AOL

    www.aol.com/2011/09/02/astrazenecas-crestor...

    AstraZeneca (NYS: AZN) just lost a potential marketing edge for Crestor. In trial results announced today, the statin drug failed to best Lipitor at clearing clogged arteries, at least in a ...

  3. Pfizer Plans Direct-to-Consumer Lipitor Sales - AOL

    www.aol.com/2011/11/22/pfizer-plans-direct-to...

    Lately, almost every day we've heard of a new Pfizer (NYS: PFE) strategy for hanging on to Lipitor sales after the drug faces generic competition. Discounts, co-pay cards, rebates, conversion to ...

  4. Why CVS Charges $133 More Than Costco for Generic Lipitor - AOL

    www.aol.com/news/2013-04-03-cvs-costco-generic...

    Jb Reed, Bloomberg via Getty Images By Emily Jane Fox CVS (CVS) charges $150 for a monthly prescription of the generic version of the cholesterol drug Lipitor. The same drug goes for $17 at Costco.

  5. Atorvastatin - Wikipedia

    en.wikipedia.org/wiki/Atorvastatin

    From 1996 to 2012, under the trade name Lipitor, atorvastatin became the world's best-selling medication of all time, with more than $125 billion in sales over approximately 14.5 years. [ 119 ] and $13 billion a year at its peak, [ 120 ] Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."

  6. List of largest selling pharmaceutical products - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_selling...

    The top 5 best selling pharmaceuticals 2015–2019. Sales in billion USD. [1] Rank Drug Main indication ... Cholesterol: Jun-2001: Mon-20XX 60: Prezista: Darunavir ...

  7. Ezetimibe/atorvastatin - Wikipedia

    en.wikipedia.org/wiki/Ezetimibe/atorvastatin

    Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug.In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [1]